Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Analysts are anticipating strong growth driven by the robust sales of Lilly's https://graysonzvmv070488.vblogetin.com/43344740/eli-lilly-stock-a-deep-dive-into-q3-earnings